Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors.

Liu, Zhihe; Fan, Hongqiong; Li, Yuying; Liu, Chunshui

Liu, Zhihe; Fan, Hongqiong; Li, Yuying; Liu, Chunshui.

Afiliación

Liu Z; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, People's Republic of China.
Fan H; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, People's Republic of China.
Li Y; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, People's Republic of China.
Liu C; Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, People's Republic of China.

Onco Targets Ther ; 10: 3515-3520, 2017.

Article en En | MEDLINE | ID: mdl-28761360

Palabras clave

BCR/ABL1; EFS; MPNs; bone marrow; chronic phase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2017 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google